FDA Evaluation Of Risk Management Plans And “Tools” Needed, PhRMA Says

FDA should undertake a review of all current and past risk management plans and "tools" to document their effectiveness, PhRMA says

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet